Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Effect of monthly intravenous cyclophosphamide in rapidly deteriorating multiple sclerosis patients resistant to conventional therapy.
Right Under Our Noses: Olfactory Pathology In Central Nervous System Demyelinating Diseases
Effects of the Anti-Multiple Sclerosis Immunomodulator Laquinimod on Anxiety and Depression in Rodent Behavioral Models.
FTY720 is neuroprotective after cuprizone-induced central nervous system demyelination.
Peripheral neuropathy associated with mitochondrial disease in children.
The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology.
Synthon Announces Successful Outcomes from the Open-label extension of the Phase III GATE Study of Synthon’s Glatiramer Acetate
The anti-inflammatory effect of donepezil on experimental autoimmune encephalomyelitis in C57 BL/6 mice.
In multiple sclerosis oligoclonal bands connect to peripheral B cell responses.
Riluzole increases glutamate uptake by cultured C6 astroglial cells.
Effects of dual-task balance training on postural performance in patients with Multiple Sclerosis: A double-blind, randomized controlled pilot trial.
Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge.
Characteristics of persons with overactive bladder of presumed neurologic origin: Results from the boston area community health (BACH) survey.
Natalizumab to fingolimod washout in patients at risk of PML: When good intentions yield bad outcomes.
[Unified assessment of adverse events of multiple sclerosis disease modifying drugs.]
T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial.
Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis.
MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T.
Progressive outer retinal necrosis in a multiple sclerosis patient on natalizumab.
Perceived impact of spasticity is associated with spatial and temporal parameters of gait in multiple sclerosis.
Correlation of nitric oxide levels in the cerebellum and spinal cord of experimental autoimmune encephalomyelitis rats with clinical symptoms.
Clinically meaningful performance benchmarks in MS: Timed 25-Foot Walk and the real world.
Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive.
Complementary and Alternative Medicine Use and Nutrient Intake Among Individuals with Multiple Sclerosis in the United States.
Biomarkers for multiple sclerosis.

Pages